Philips announces first patient enrollment in DEFINE GPS global multicenter study to assess superiority of PCI procedures guided by co-registered iFR and interventional angiography GlobeNewswire June ...
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the official start of the DEFINE GPS study, with the first patient being enrolled by the study’s Principal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback